People
“This agreement builds on Gilead’s presence in immuno-oncology and adds significant potential to our clinical pipeline,” said Daniel O’Day, Gilead’s chairman and chief executive officer.
Co-founder of Brisbane-based gut analysis company Microba, Professor Gene Tyson, will head up a new field of microbiome-focused research at the Queensland University of Technology.
The company expects to decrease its operating expenses by about 40% this year compared to 2019.
The novel coronavirus that causes the disease COVID-19 continues to spread and has now been diagnosed in more than 50 countries.
Brandicourt stepped down from his role as chief executive officer of Sanofi last year.
Biopharma and life sciences strengthen their executive leadership teams and boards with this week’s Movers & Shakers.
A look at how two biotech professionals made the transition from research to inspiring students as biotech teachers with the help of EnCorps STEM Teachers Program.
Christopher Anzalone, Arrowhead’s chief executive officer, took time to speak with BioSpace about the company’s large pipeline and why they’re so excited about 2020.
After four years with the gene therapy company, Chief Medical Officer Kathleen Reape will resign her position.
The changes are designed to extend the company’s cash runway to the end of 2021.
PRESS RELEASES